Selecta Biosciences

Selecta Biosciences

Pioneering RNA cell therapy for autoimmune disease.

Launch date
Employees
Market cap
CAD488m
Enterprise valuation
CAD197m (Public information from Sep 2024)
Watertown Massachusetts (HQ)
Authorizing premium user...